EUVIMEDEUVIMED entdecken
Crossref

11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies

Ali Kabli, Ahmed Bamaga, Raed Gasemaltayeb, Mohammed Karami, Alaa Alkhotani, Majid Almansouri, Hussain Noorwali, Motaz Fadul, Adnan Badahdah, Riffat Mehboob, Abdulaziz Alqarni, Khalid Khashoggi und 5 weitere

Folia Neuropathologica · 2026 · 64 (2) · 142-149

DOI: 10.5114/fn.2026.163679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Neuropathologica, 2026. Verfasst von Ali Kabli und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia. Hauptthemen laut MEDLINE: Glucocorticoids, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Myositis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucocorticoids11-beta-Hydroxysteroid Dehydrogenase Type 1MyositisHumansFemaleMaleBiomarkersMiddle AgedPrednisoloneAdultTreatment OutcomeAged

Stichwörter der Autor:innen

treatment response11  -hydroxysteroid dehydrogenase type 1glucocorticoid therapyinflammatory myopathies

Substanzen

Glucocorticoids11-beta-Hydroxysteroid Dehydrogenase Type 1BiomarkersPrednisolone

Autor:innen und Institutionen

  • Department of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
  • Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
  • Department of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pathology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Zitieren

APA

Kabli, A., Bamaga, A., Gasemaltayeb, R., Karami, M., Alkhotani, A., Almansouri, M., Noorwali, H., Fadul, M., Badahdah, A., Mehboob, R., Alqarni, A., Khashoggi, K., Alkhotani, A., Fathaddin, A., Hassan, A., Waseem, H., & Kurdi, M. (2026). 11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies. Folia Neuropathologica, 64(2), 142-149. https://doi.org/10.5114/fn.2026.163679

Vancouver

Kabli A, Bamaga A, Gasemaltayeb R, Karami M, Alkhotani A, Almansouri M, et al. 11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies. Folia Neuropathologica. 2026;64(2):142-149. doi:10.5114/fn.2026.163679

BibTeX
@article{Kabli2026,
  author = {Kabli, Ali and Bamaga, Ahmed and Gasemaltayeb, Raed and Karami, Mohammed and Alkhotani, Alaa and Almansouri, Majid and Noorwali, Hussain and Fadul, Motaz and Badahdah, Adnan and Mehboob, Riffat and Alqarni, Abdulaziz and Khashoggi, Khalid and Alkhotani, Amal and Fathaddin, Amany and Hassan, Amber and Waseem, Humaira and Kurdi, Maher},
  title = {11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies},
  journal = {Folia Neuropathologica},
  year = {2026},
  volume = {64},
  number = {2},
  pages = {142--149},
  doi = {10.5114/fn.2026.163679}
}
Kostenlos starten →